Stopain Clinical to dispense more than 10 million pain relief gel sample packets annually

A conversation with Jay Greenstein, DC

Troy Healthcare, the maker of Stopain Clinical topical analgesic, has partnered with leading industrial first aid and workplace health companies to dispense more than 10 million pain relief gel sample packets annually.

This initiative aims to introduce Stopain Clinical samples to millions of individuals in workplace settings, ultimately driving them to seek treatment from chiropractic, physical therapy and massage therapy clinics. Read the full story here.

Gloria Hall, Chiropractic Economics editor-in-chief, sat down with renowned international speaker and consultant Jay Greenstein, DC, to discuss the Stopain Clinical sampling program and its impact on the chiropractic profession.

1. What is the potential impact the Stopain Clinical sampling program could have on DCs? How can DCs spread the word?

The sampling program has massive potential to introduce millions of individuals experiencing pain to chiropractic. By distributing Stopain Clinical samples through industrial first aid programs, patients who may not have considered chiropractic treatment will be directed toward professionals who can address the root cause of their discomfort. Additionally, employers paying for healthcare will see the clinical and cost-effectiveness benefits of non-pharmacological, conservative, holistic care. This creates a unique opportunity for DCs to gain new patients who are actively seeking pain relief and educate employers on how they can keep their employees healthy at a lower cost than standard medical care.

DCs can spread the word by:

• Educating current patients about the benefits of Stopain Clinical and the importance of professional care for long-term relief
• Promoting the program through their website, email marketing and social media
• Partnering with local workplaces to provide Stopain Clinical samples and informational materials about chiropractic care
• Highlighting their participation in the program in-office and online, ensuring those searching for relief can easily find them.

2. How long have you been on Stopain’s clinic locator? What are the benefits of being listed?

I have been listed on the Stopain Clinical [Clinic] Locator since its inception in 2017. The primary benefit is visibility—potential patients who receive Stopain Clinical samples and search for providers are directly guided to our clinics. This targeted traffic increases the likelihood of acquiring new patients who are already familiar with the product and motivated to seek care. Additionally, being associated with a trusted brand like Stopain Clinical reinforces credibility and provides another avenue for patient acquisition.

3. Are you able to track the leads you get from the clinic locator?

Yes, tracking leads from the clinic locator is possible through multiple methods, such as:

• Asking new patients how they found the clinic during intake
• Using specific call-to-action tracking (e.g., unique phone numbers or landing pages for Stopain Clinical patients)
• Monitoring appointment requests that reference Stopain Clinical

While the locator itself may not provide direct analytics, combining these strategies allows me to measure the impact of the listing.

4. Can you explain how this program has worked for you (the benefits)?

The Stopain Clinical program has provided a consistent stream of highly qualified leads—patients who are already experiencing pain and looking for solutions beyond temporary relief. In addition, by using the product as part of our clinical approach, we enhance patient outcomes and improve retention. When patients feel better, it builds trust. Trust builds retention. And integrating Stopain Clinical into our treatment recommendations has created a new revenue stream while reinforcing our position as a trusted provider of effective pain relief solutions.

 5. Why should DCs get listed on Stopain’s clinic locator?

Getting listed on the Stopain Clinical [Clinic] Locator is a no-brainer for any DC looking to expand their patient base. First of all, it’s FREE! The program provides a direct pathway for individuals already seeking pain relief to connect with qualified DCs. Unlike traditional marketing, this approach targets individuals who are motivated to take action, leading to higher conversion rates. It also positions DCs as trusted pain management professionals, bridging the gap between immediate relief and long-term neuromusculoskeletal health.

6. What makes Stopain Clinical a superior product, and why should other DCs offer Stopain?

Stopain Clinical stands out due to its high-quality formulation featuring 10% menthol, delivering fast-acting and effective pain relief. Unlike over-the-counter alternatives, Stopain Clinical is exclusively available through healthcare professionals, reinforcing the credibility of chiropractic care as an essential part of pain management.

For DCs, Stopain Clinical is an ideal addition to practice offerings because:

• Patients get immediate relief, increasing trust and satisfaction with their care.
• The gel serves as a gateway to additional services, converting product users into long-term patients.
• The product creates an additional revenue stream while maintaining high profit margins.
• This topical aligns with evidence-based care, supporting active recovery rather than just masking symptoms.

By offering Stopain Clinical, DCs not only provide an effective pain relief solution but also strengthen patient engagement and clinical outcomes, and [it] turns patients into raving, referring fans!

Final thoughts

The integration of Stopain Clinical samples into industrial first aid programs will serve as a catalyst for growth of the brand. It will also help introduce millions of pain sufferers to their local doctor of chiropractic and other helpful health and wellness solutions.

For more information, visit stopainclinical.com.

JAY GREENSTEIN, DC, is the founder and CEO of the Kaizo Health Companies and the founder and CEO of EMBODI, a remote therapeutic monitoring platform for DCs. Greenstein is the past chairman of the ChiroTech Consortium for the Chiropractic Future Strategic Plan and currently sits on the leadership team. He is the past chairman of the Federation of International Chiropractic du Sport’s World Olympians Scholarship Program and past chairman for the Clinical Compass. Greenstein is a sought-after international speaker and consultant, teaching on the topics of evidence into practice, leadership, business management and emerging technologies. He sits on multiple advisory boards in healthcare and technology. Reach him at drjay@kaizo-health.com.